Anatomical segmentectomy versus wedge resection in high-risk operable patients with clinical stage IA non-small cell lung cancer: A randomized phase III trial. - Anatomical segmentectomy versus wedge resection in high-risk operable patients with clinical stage IA non-small cell lung cancer: A randomized phase III trial.

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 370 人开始时间: 2020年4月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) History of synchronous or metachronous (within 2 years) malignancies with 5-year relative survivals of less than 95% at the time of diagnosis.) (2) Active infection requiring systemic therapy. (3) Fever of higher than 38.0 degrees Celsius at the time of enrollment. (4) Pregnant, possibly pregnant, within 28 days after delivery, breastfeeding female or males expecting conception of their child. (5) Psychiatric illnesses or symptoms affecting daily lives. (6) Systemic administration of steroids or immunosuppressive agents either orally or intravenously. (7) Uncontrollable diabetes (HbA1c > 8%). (8) Uncontrollable hypertension. (9) Unstable angina (diagnosis or worsening of chest pain within 3 weeks) or history of myocardial infarction within 6 months prior to enrollment. (10) Uncontrollable heart valve disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy. (11) Diagnoses of interstitial pneumonia, pulmonary fibrosis, or both, on chest CT.

发起方

Japan Clinical Oncology Group (JCOG)